Cargando…
GDF15 Is an Eribulin Response Biomarker also Required for Survival of DTP Breast Cancer Cells
SIMPLE SUMMARY: Drug tolerant persister (DTP) cells are a unique, small sub-population of cancer cells that maintain viability under anti-cancer cytotoxic treatments. These cells enter into a reversible drug-tolerant state, which is believed to be the root of tumor recurrence. Therefore, there is a...
Autores principales: | Bellio, Chiara, Emperador, Marta, Castellano, Pol, Gris-Oliver, Albert, Canals, Francesc, Sánchez-Pla, Alex, Zamora, Esther, Arribas, Joaquín, Saura, Cristina, Serra, Violeta, Tabernero, Josep, Littlefield, Bruce A., Villanueva, Josep |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9139899/ https://www.ncbi.nlm.nih.gov/pubmed/35626166 http://dx.doi.org/10.3390/cancers14102562 |
Ejemplares similares
-
Circulating SOD2 Is a Candidate Response Biomarker for Neoadjuvant Therapy in Breast Cancer
por: Juliachs, Mercè, et al.
Publicado: (2022) -
Diseño para la autoedición (DTP) /
por: Collier, David, 1966-
Publicado: (1992) -
DTP: the complete guide to corporate desktop publishing
por: Jones, Robert
Publicado: (1988) -
Nitroimidazole-based inhibitors DTP338 and DTP348 are safe for zebrafish embryos and efficiently inhibit the activity of human CA IX in Xenopus oocytes
por: Aspatwar, Ashok, et al.
Publicado: (2018) -
The Association between Childhood Immunization and Gender Inequality: A Multi-Country Ecological Analysis of Zero-Dose DTP Prevalence and DTP3 Immunization Coverage
por: Vidal Fuertes, Cecilia, et al.
Publicado: (2022)